What is MBX Biosciences, Inc.'s net change in cash?

MBX Biosciences, Inc. (MBX) reported net change in cash of -$29.87M in Q1 2026.

How has MBX Biosciences, Inc.'s net change in cash changed year-over-year?

MBX Biosciences, Inc.'s net change in cash decreased by 53.6% year-over-year, from -$19.45M to -$29.87M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

MBX Biosciences, Inc. MBX Net Change in Cash

Net Change in Cash at other companies

Eli LillyLLY

-$1.99B-1,035%

AmgenAMGN

$2.91B+192%

Viking TherapeuticsVKTX

-$47.71M-524%

Amylyx Pharmaceuticals, Inc.AMLX

$2.49M+114%

BridgeBio PharmaBBIO

$309.88M+321%

Nurix Therapeutics, Inc.NRIX

-$175.77M-416%

Other financials

Income statement

See full

Operating income-$27.3M-2.8%

Net income-$23.5M+1.5%

EPS (diluted)-$0.50+29.6%

Balance sheet

See full

Cash & equivalents$45.2M+51.2%

Total debt$555.0K+327%

Total equity$437.8M+85.9%

Total assets$452.7M+84.1%

Cash flow

See full

Operating cash flow-$20.2M+10.9%

CapEx$437.0K+1,357%

Free cash flow-$20.6M+9.1%

Valuation

See full

Market cap$2.21B+475%

Enterprise value$2.16B+533%

Returns & leverage

See full

Return on equity-25.7%—

Debt / equity0×0.0×

Current ratio30.8×+7.5×

Where this comes from

Reported directly by MBX Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about MBX Biosciences, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MBX Biosciences, Inc.'s net change in cash?: MBX Biosciences, Inc. (MBX) reported net change in cash of -$29.87M in Q1 2026.
How has MBX Biosciences, Inc.'s net change in cash changed year-over-year?: MBX Biosciences, Inc.'s net change in cash decreased by 53.6% year-over-year, from -$19.45M to -$29.87M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.